Mylan Inc.today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA) for Carbidopa and Levodopa Tablets USP, 10mg/100mg, 25mg/100mg and 25mg/250 mg.
The details can be read here.
No comments:
Post a Comment